Ohad Karnieli, Founder and CEO of Adva Biotechnology, discusses the clinical potential for cell and gene therapies, as well as the gap that needs bridging in order to transform advanced therapies from scientific success to available cures.
In this short interview, Ohad discusses where we are in revolutionizing cancer treatment, as well as what gaps still need to be bridged in delivering advanced therapies to patients.
Hear more from Ohad at Advanced Therapies Europe – join his session at 13:30 on Wednesday 31st August, titled, ‘Exploring the Shift Towards Point-of-Care Automation & Decentralised Manufacturing.
The contract and research organization (CRO) AmplifyBio has announced the acquisition of select assets from privately held biopharmaceutical company PACT Pharma Inc to advance its cell and gene therapy service offerings.
For this Article, Phacilitate Editor, Georgi Makin, explores current challenges associated with CAR-T manufacturing workflows, considering how an integrated testing approach could reduce costs and accelerate speed to market.